Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
JNJ | Johnson & Johnson | 63.8 | $465,600.00 | US |
PFE | Pfizer Inc. | 86.9 | $284,248.00 | US |
ABBV | AbbVie, Inc. | 64.4 | $269,467.00 | US |
DHR | Danaher Corporation | 62.7 | $183,136.00 | US |
ZTS | Zoetis, Inc. Class A | 56.9 | $80,063.40 | US |
Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
CODX | Co-Diagnostics, Inc. | 80.2 | $173.00 | US |
SMLR | Semler Scientific, Inc. | 62.4 | $198.15 | US |
IRMD | IRadimed Corp. | 65.9 | $423.55 | US |
CARA | Cara Therapeutics Inc | 28.3 | $496.26 | US |
ORGO | Organogenesis Holdings, Inc. Class A | 72.3 | $612.08 | US |
Symbol | Name | Grade | Times* | Country |
---|---|---|---|---|
WAT | Waters Corporation | 69.2 | 37 | US |
JNJ | Johnson & Johnson | 63.8 | 36 | US |
REGN | Regeneron Pharmaceuticals, Inc. | 80.2 | 32 | US |
GMED | Globus Medical Inc Class A | 49.2 | 26 | US |
VIVO | Meridian Bioscience, Inc. | 72.1 | 25 | US |
CHE | Chemed Corporation | 58.8 | 23 | US |
INVA | Innoviva, Inc. | 69.5 | 22 | US |
COO | Cooper Companies, Inc. | 49.5 | 21 | US |
CORT | Corcept Therapeutics Incorporated. | 71.0 | 18 | US |
ABBV | AbbVie, Inc. | 64.4 | 18 | US |
Average Market Cap | $45,283.64 |
Median Market Cap | $7,012.46 |
Avg. 3 Mo. Dollar Vol. | $216,677,695.83 |
Avg. 3 Mo. Trading Vol. | 1,940,995 |
Last Rebalance Date | 02/22/2022 |
Companies Replaced | 10 |
Biggest Industry Increase | Pharmaceuticals: Major |
Biggest Industry Decrease | Medical Specialties |
Companies Overlapping S&P 500 | 18 |
Trailing P/E Ratio (12 Mo.) | 18.0 |
Forward P/E Ratio (12 Mo.) | 21.38 |
Price/Book Ratio | 3.51 |
Avg. Revenue Chg. - 3 Yr | 53.2% |
Avg. Op. Income Chg. - 3 Yr. | 122.01% |
Avg. EPS Growth - 3 Yr. | 30.12% |
Avg. EPS Growth - 1 Yr. | 23.37% |
Avg. Operating Margin | 26.45% |
Avg. LT Debt to Total Capital | 18.22% |
Avg. Return on Equity | 28.22% |
Dividend Yield | 0.0% |
MarketGrader Health Care Index | 67.47 |
United States Of America | 95.0% |